$LGND

$290.00▲ -0.0% YTD

5 SEC 13D/G filings tracked · Last updated Sep 22, 2026

Filing History

LGND ▼ -0.0% - Ligand Pharmaceuticals Incorporated

CP $290.00▲ -0.0%Sep 22, 2026 · ThinkSabio Blog

$LGND - Sydnexis Announces Royalty Agreement with Ligand for Ryjunea®…

LGND ▼ -0.0% - Ligand Pharmaceuticals Incorporated

CP $290.00▲ -0.0%Sep 22, 2026 · ThinkSabio Blog

$LGND - Primrose Bio® Raises Significant Growth Capital Investment Led by Signet Healthcare Partners…

LGND ▼ -0.0% - Ligand Pharmaceuticals Incorporated

CP $290.00▲ -0.0%Sep 22, 2026 · ThinkSabio Blog

$LGND Sydnexis Announces Royalty Agreement with Ligand for Ryjunea®…

LGND ▼ -0.0% - Ligand Pharmaceuticals Incorporated

CP $290.00▲ -0.0%Sep 22, 2026 · ThinkSabio Blog

$LGND - Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million…

LGND - Ligand Pharmaceuticals Incorporated - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified

$287.27▲ 51.38%Aug 13, 2026 · ThinkSabio Blog

$LGND SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #LGND Ligand Pharmaceuticals Incorporated : $287.27 Sector: Heal…